Digital Health Monthly: Scientific Webinar Series
Introducing 6M95C: A Novel Digital Measure for Tracking Disease Progression in Duchenne Muscular Dystrophy
Wednesday, January 28, 2026 @ 12 PM ET
Upcoming Digital Health Monthly:
Scientific Webinar Series
Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies
Tuesday, December 3 @ 12 PM ET
Digital Health Monthly: Scientific Webinar Series
Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.
As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.
Accurately capturing disease progression across the full spectrum of Duchenne muscular dystrophy (DMD) remains a persistent clinical research challenge, especially as patients transition from ambulatory to non-ambulatory stages. Stride Velocity 95th Centile (SV95C) is a regulatory-qualified digital endpoint that objectively measures functional capacity in ambulatory patients with DMD. However, SV95C cannot be captured once ambulation is lost, leaving a critical gap in assessing functional capacity later in the disease course.
A new research study published in Pediatric Neurology introduces the Six-Minute Activity 95th Centile (6M95C), a novel accelerometry-based digital measure designed to complement SV95C by providing a sensitive, real-world view of functional capacity across disease stages, including when patients are no longer ambulatory.
In the first Digital Health Monthly webinar of 2026, several authors of the study, including Ametris scientists Rakesh Pilkar and Andrew Liu, will discuss the development and clinical implications of 6M95C in DMD research. Join us on January 28th to learn how continuous, real-world monitoring can unlock more sensitive and objective measures of functional capacity and disease progression in DMD.
Register now to save your spot! Can’t make the live presentation? Register today and receive the on-demand presentation delivered to your inbox.
